Kyowa Kirin International plc.
Jill Flint has extensive work experience in regulatory affairs, with a focus on CMC (Chemistry, Manufacturing, and Controls). Jill is currently the Global Head of Regulatory Affairs - CMC at Kyowa Kirin International plc., a position they have held since July 2021. Prior to this role, they served as the Director of Regulatory Affairs - CMC and Associate Director of Regulatory Affairs - CMC at the same company.
Before joining Kyowa Kirin International, Jill worked as a Regulatory Affairs Consultant specializing in CMC from October 2012 to June 2015. Jill was responsible for biotech, CMC IND/IMPD/CTA maintenance and played a key role in the strategy and submission of BLA (Biologics License Application).
From September 2011 to October 2012, Jill worked as a Regulatory Affairs Manager at Seven Seas Limited, where they managed a team of regulatory professionals and handled registrations, renewals, and variations to support the company's business activities.
Jill's career in regulatory affairs began at Ipsen in 2007, where they held various roles. Jill served as a Quality Regulatory Specialist from November 2009 to September 2011, responsible for the authoring and maintenance of CMC/M3 sections of product licenses. Prior to this, they worked as a Regulatory Compliance Officer and Associate Manager, managing technical projects and writing technical protocols and reports.
Overall, Jill Flint has over a decade of experience in regulatory affairs, with a strong focus on CMC. Jill has held progressively senior positions throughout their career and has gained extensive knowledge and expertise in the field.
Jill Flint attended the University of Liverpool from 2002 to 2005, where they received a Bachelor of Science (BSc) degree in Physiology. Prior to that, they attended Duchess's High School in Alnwick from 1996 to 2001.
This person is not in any offices
Kyowa Kirin International plc.
At Kyowa Kirin International (KKI), commitment to life is at our core. We strive to answer the unmet medical needs of patients, their families, and the medical professionals who care for them. With more than 700 people focused on this purpose, we are a rapidly growing specialty biopharmaceutical company, engaged in the development and commercialisation of innovative medicines in the therapy areas of oncology, nephrology and central nervous system (CNS) across Europe and the Middle East. KKI, headquartered in Marlow, England, and Galashiels, Scotland, is owned by Kyowa Kirin Co., Ltd (KKC), of Japan. Founded in 1949, KKC has a successful track record in Japan and has expanded globally. Our history of innovation is built on a strong legacy of scientific discovery and fostering collaborations that accelerate the delivery of innovative medicines to patients. Grounded in our expertise in antibody engineering, we continue to investigate new molecules with the potential to contribute to the future of healthcare and make a difference in the lives of patients. At KKI, it is our people who have helped make a real difference to our success. Working together, our employees excel in achieving results quickly and effectively, bringing diverse and unique viewpoints to the company to achieve our vision. Our passion and energy around our core values of commitment to life, innovation, integrity and teamwork help ensure that every day, each of us is focused on not just making medicines, but also making people smile. With our strong legacy and exciting future, KKI is looking for great people to join our team and support our commitment to life.